| Next-generation sequencing technology: current trends and advancements H Satam, K Joshi, U Mangrolia, S Waghoo, G Zaidi, S Rawool, ... Biology 12 (7), 997, 2023 | 80 | 2023 |
| Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity M Pandey, AK Singh, R Thakare, S Talwar, P Karaulia, A Dasgupta, ... Scientific Reports 7 (1), 11521, 2017 | 42 | 2017 |
| Repurposing disulfiram for treatment of Staphylococcus aureus infections R Thakare, M Shukla, G Kaul, A Dasgupta, S Chopra International journal of antimicrobial agents 53 (6), 709-715, 2019 | 41 | 2019 |
| Teixobactin: a paving stone toward a new class of antibiotics? VB Gunjal, R Thakare, S Chopra, DS Reddy Journal of medicinal chemistry 63 (21), 12171-12195, 2020 | 37 | 2020 |
| Repurposing Ivacaftor for treatment of Staphylococcus aureus infections R Thakare, AK Singh, S Das, N Vasudevan, GR Jachak, DS Reddy, ... International journal of antimicrobial agents 50 (3), 389-392, 2017 | 36 | 2017 |
| Repurposing nonantibiotic drugs as antibacterials R Thakare, G Kaul, M Shukla, P Kesharwani, N Srinivas, A Dasgupta, ... Drug Discovery Targeting Drug-Resistant Bacteria, 105-138, 2020 | 19 | 2020 |
| Antibiotics: past, present, and future R Thakare, P Kesharwani, A Dasgupta, N Srinivas, S Chopra Drug discovery targeting drug-resistant bacteria, 1-8, 2020 | 19 | 2020 |
| Delamanid for the treatment of pulmonary multidrug-resistant tuberculosis R Thakare, I Soni, A Dasgupta, S Chopra Drugs Today 51 (2), 117, 2015 | 19 | 2015 |
| Eravacycline for the treatment of patients with bacterial infections. R Thakare, A Dasgupta, S Chopra Drugs of Today (Barcelona, Spain: 1998) 54 (4), 245-254, 2018 | 16 | 2018 |
| Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A … R Misra, R Thakare, N Amrin, KN Prasad, S Chopra, TN Dhole Transactions of The Royal Society of Tropical Medicine and Hygiene 110 (8 …, 2016 | 16 | 2016 |
| Update on nifurtimox for treatment of Chagas disease. R Thakare, A Dasgupta, S Chopra Drugs of today (Barcelona, Spain: 1998) 57 (4), 251-263, 2021 | 15 | 2021 |
| Ligand-free Pd-catalysed decarboxylative arylation of imidazo [1, 2-a] pyridine-3-carboxylic acids with aryl bromides UB Karale, S Kalari, J Shivakumar, VB Makane, DA Babar, RP Thakare, ... RSC advances 6 (69), 65095-65104, 2016 | 14 | 2016 |
| Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial A Kumar, VM Boradia, R Thakare, AK Singh, Z Gani, S Das, A Patidar, ... Journal of Antimicrobial Chemotherapy 74 (4), 912-920, 2019 | 12 | 2019 |
| Pretomanid for the treatment of pulmonary tuberculosis. R Thakare, A Dasgupta, S Chopra Drugs of Today (Barcelona, Spain: 1998) 56 (10), 655-668, 2020 | 8 | 2020 |
| Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections AK Singh, R Thakare, P Karaulia, S Das, I Soni, M Pandey, AK Pandey, ... Journal of Antimicrobial Chemotherapy 72 (11), 3117-3121, 2017 | 8 | 2017 |
| Molnupiravir for the treatment of COVID-19 BG Santani, BW LeBlanc, RP Thakare Drugs Today (Barc) 58 (7), 335-50, 2022 | 7 | 2022 |
| Lascufloxacin hydrochloride to treat bacterial infection R Thakare, S Singh, A Dasgupta, S Chopra Drugs Today 56 (6), 365, 2020 | 7 | 2020 |
| An update on benznidazole for the treatment of patients with Chagas disease. R Thakare, A Dasgupta, S Chopra Drugs of Today (Barcelona, Spain: 1998) 54 (1), 15-23, 2018 | 6 | 2018 |
| Imipenem/cilastatin sodium/relebactam fixed combination to treat urinary infections and complicated intra-abdominal bacterial infections R Thakare, A Dasgupta, S Chopra Drugs Today (Barc) 56 (4), 241-255, 2020 | 5 | 2020 |
| Triclabendazole for the treatment of fascioliasis R Thakare, A Dasgupta, S Chopra Drugs Today 55 (12), 743, 2019 | 5 | 2019 |
